Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Equitable Group Inc. (EQB-T) announced that it has selected Barclays Bank PLC and TD Securities to help its Equitable Bank subsidiary with developing a covered bond funding program. “Management’s goal is to launch the program as early as 2020, subject to regulatory approval of its program and market conditions. Assuming success with this timetable, Equitable would likely become the first mid-sized Canadian bank to launch a covered bond program,” the company stated.

**

Medicure Inc. (MPH-X) announced that its Medicure International Inc. subsidiary has settled its ongoing patent infringement action against Gland Pharma Ltd. in the U.S. District Court for the District of New Jersey, which alleged infringement of one of Medicure’s U.S. patents.

"As part of the settlement, Gland has acknowledged that the '660 patent is valid, enforceable and infringed," the company stated. "The settlement results in the company entering into a license agreement with Gland with an anticipated launch date for Gland's generic product of March 1, 2023. The remaining terms of the settlement are confidential."

**

Cresco Labs Inc. (CL-C) reported second-quarter revenue of $29.9-million, up 253 per cent year-over-year. and ahead of expectations of $27.9-million. Its net loss of $3.9-million, compared to net income of $1.6-million in the prior-year period

**

Kirkland Lake Gold Ltd. (KL-T) increased its stake in Bonterra Resources Inc. (BTR-X) to 11.3 per cent from 10.2 per cent on a non-diluted basis. The company said it bought 2 million units in a private placement financing at a price of $2.50 per unit for a total cash payment of $5-million. Each Unit is comprised of one common share and one-half of one share purchase warrant. Each full warrant entitles the company to acquire one share at a price of $3.10 until August 20, 2021.

**

Well Health Technologies Corp. (WELL-X) reported that its revenue increased 258 per cent to $7.4-million in the three-month period ended June 30, compared $2.1-million in the three months ended July 31, 2018 and ahead of expectations of $6.96-million. Its net loss from continuing operations was $1.7-million or 2 cents per share, which was in line with expectations and compared to a loss of $633,270 or a penny per share in the second quarter of last year.

**

TerrAscend Corp. (TER-C) reported second-quarter revenue of $17.6-million up from $9,000 a year ago. Its net loss was $21.5-million or 37 cents per share compared to $5.2-million or 5 cents a year ago. The company also raised its guidance and says revenues are now expected to exceed $141-million1 in 2019, up from $135-million as previously announced on April 15.

**

Report an editorial error

Report a technical issue

Editorial code of conduct

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 28/03/24 0:35pm EDT.

SymbolName% changeLast
CL-CN
Cresco Labs Inc
-6.23%2.86
MPH-X
Medicure Inc
-4.17%1.15
EQB-T
EQB Inc
-0.14%84.84
BTR-X
Bonterra Resources Inc
0%0.23

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe